Global Pharmaceutical Contract Manufacturing and Contract Market Growth (Status and Outlook) 2022-2028

As the global economy mends, the 2021 growth of Pharmaceutical Contract Manufacturing and Contract will have significant change from previous year. According to our (LP Information) latest study, the global Pharmaceutical Contract Manufacturing and Contract market size is USD million in 2022 from USD 85920 million in 2021, with a change of % between 2021 and 2022. The global Pharmaceutical Contract Manufacturing and Contract market size will reach USD 134740 million in 2028, growing at a CAGR of 6.6% over the analysis period.
The United States Pharmaceutical Contract Manufacturing and Contract market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Pharmaceutical Contract Manufacturing and Contract market, reaching US$ million by the year 2028. As for the Europe Pharmaceutical Contract Manufacturing and Contract landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Pharmaceutical Contract Manufacturing and Contract players cover Catalent, Thermo Fisher Scientific, Lonza, and Boehringer Ingelheim, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Pharmaceutical Contract Manufacturing and Contract market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Oral
Injectable
API
Other
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Small Medium Enterprise
Large Enterprise
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Catalent
Thermo Fisher Scientific
Lonza
Boehringer Ingelheim
Fareva
Recipharm
Aenova
AbbVie
Baxter
Nipro Corp
Sopharma
Famar
Vetter
Shandong Xinhua
Piramal
Mylan
Dr. Reddy’s
Zhejiang Hisun
Zhejiang Huahai
Jubilant